However, recent evidence from human genetics [45, 52], neuroimaging [14], and in-vivo modeling [9] has strongly implicated additional disease mechanisms in AD, not reflected by the established Aβ and tau biomarkers. The gene discussed is MAPT; the disease is Alzheimer disease.